EyePoint, Inc.EYPT

NasdaqHealthcareLaboratory Analytical Instruments
Price (close)
$3.65
Market cap
$310.2M
P/E
—
Revenue (TTM)
$2.8M
Net income
-$306.6M
Dividend yield
—
1-year total return
-72.3%
Net margin
-10994.7%
Revenue growth
-94.6%
Debt / equity
—

What EyePoint, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$34.4M$36.9M$41.4M$46.0M$43.3M$31.4M
Net income-$45.4M-$58.4M-$102.3M-$70.8M-$130.9M-$232.0M
Free cash flow-$14.8M-$50.3M-$67.2M-$1.6M-$130.3M-$243.4M

More on EYPT.

Figures from EyePoint, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.